Clinical trial
Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic…
NCT00405210 · Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Other · Completed
Key facts
| NCT number | NCT00405210 |
|---|---|
| Title | Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer |
| Official title | Open-label, Multicenter,PhaseI Trial in Order To Determine the Safety and Pharmacokinetics of BAY43-9006 in Combination With Docetaxel as First-line Treatment in Metastatic Hormone Refractory Prostate Cancer Patients |
| Lead sponsor | Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Primary Disease, Prostate Cancer |
| Intervention type | Drug |
| Interventions | sorafenib (200 or 400mg bid) and taxotere iv |
| Enrollment | 38 |
| Start date | Sep 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Nov 29, 2006 |
| Last update posted | May 23, 2011 |
| Countries | Belgium, France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: